Home > AstraZeneca

AstraZeneca Receive US FDA Approval for its Lung Cancer Drugs

The US Food and Drug Administration (FDA) approved AstraZeneca’s cancer drugs Imfinzi and Imjudo in combination with chemotherapy to treat patients with stage 4 non-small cell lung cancer. This approval is based on the phase 3 data published in September 2021. Imfinzi and Imjudo with chemotherapy have shown an overall 23

Read More

AstraZeneca and Sanofi gets European Approval for Drugs Preventing RSV for Infants

The European Commission (EC) approved Beyfortus, jointly developed by AstraZeneca and Sanofi, for the prevention of a common and highly contagious type of respiratory infection in infants. This long-acting therapy, which is also known as nirsevimab, was given marketing authorisation in the European Union (EU) for the prevention of disease from

Read More

US FDA Warns, AstraZeneca’s Evusheld Ineffective against Omicron COVID-19 variants

The US Food and Drug Administration (FDA) of the United States, AstraZeneca’s Evusheld is proving ineffective against Omicron COVID-19 variants. Amid new reports, the antibody combination is ineffective against the latest subvariant of Omicron COVID-19 variants, including BA.4.6. The US FDA said that it can increase the risk of COVID-19 infection

Read More

AstraZeneca Enhertu Secures US FDA Approval for HER2-Low Breast Cancer

The US Food and Drug Administration (FDA) has approved Enhertu of AstraZeneca and Daiichi Sankyo for the treatment of adult patients with metastatic HER2-low breast cancer, who have received a prior chemotherapy in the metastatic setting during six months of completing adjuvant chemotherapy. Enhertu is a specifically designed HER2-directed antibody drug

Read More

AstraZeneca and Huma Partner to Accelerate Innovation for Digital-First Patient Care

Huma Therapeutics Limited, a digital health technology company has announced partnership with AstraZeneca for the purpose of scaling the innovation of digital health. This partnership has been following the prior use cases have been executed between AstraZeneca and Huma has been reflecting a shared ambition for the purpose of improving

Read More

Study: AstraZeneca Covid-19 Drug Neutralizes Sub-variants of Omicron

The pharmaceutical company ‘AstraZeneca’ said, the antibody-based cocktail of the company for the prevention and treatment of the novel corona virus had been showing to retain the neutralization activity against the Omicron corona virus variants that is including the highly contagious BA.2 sub variant of the Omicron in a study

Read More

UK MHRA Approves Antibody Cocktail for Covid-19 by AstraZeneca

The UK MHRA (Medicines and Healthcare products Regulatory Agency) has now granted the authorization to the Evusheld of AstraZeneca for the pre-exposure prophylaxis (PrEP) against the novel corona virus, and the Evusheld has been a cocktail of the two monoclonal long-acting antibodies, along with the cilgavimab and tixagevimab. The company ‘AstraZeneca’

Read More